Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial

Overview of attention for article published in Journal for Immunotherapy of Cancer, June 2016

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 747 followers.

Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell… https://t.co/mnGP6F2JTz

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.